Related Research Articles
Neuropsychopharmacology, an interdisciplinary science related to psychopharmacology and fundamental neuroscience, is the study of the neural mechanisms that drugs act upon to influence behavior. It entails research of mechanisms of neuropathology, pharmacodynamics, psychiatric illness, and states of consciousness. These studies are instigated at the detailed level involving neurotransmission/receptor activity, bio-chemical processes, and neural circuitry. Neuropsychopharmacology supersedes psychopharmacology in the areas of "how" and "why", and additionally addresses other issues of brain function. Accordingly, the clinical aspect of the field includes psychiatric (psychoactive) as well as neurologic (non-psychoactive) pharmacology-based treatments. Developments in neuropsychopharmacology may directly impact the studies of anxiety disorders, affective disorders, psychotic disorders, degenerative disorders, eating behavior, and sleep behavior.
Dan Joseph Stein is a South African psychiatrist who is a professor and Chair of the Dept of Psychiatry and Mental Health at the University of Cape Town, and Director of the South African MRC Unit on Risk & Resilience in Mental Disorders. Stein was the Director of UCT's early Brain and Behaviour Initiative, and was the inaugural Scientific Director of UCT's later Neuroscience Institute. He has also been a visiting professor at Mount Sinai School of Medicine in the United States, and at Aarhus University in Denmark.
In genetics, rs6313 also called T102C or C102T is a gene variation—a single nucleotide polymorphism (SNP)—in the human HTR2A gene that codes for the 5-HT2A receptor. The SNP is a synonymous substitution located in exon 1 of the gene where it is involved in coding the 34th amino acid as serine.
In genetics, rs6311 is a gene variation—a single nucleotide polymorphism (SNP)—in the human HTR2A gene that codes for the 5-HT2A receptor. 5-HT2A is a neuroreceptor, and several scientific studies have investigated the effect of the genetic variation on personality, e.g., personality traits measured with the Temperament and Character Inventory or with a psychological task measuring impulsive behavior. The SNP has also been investigated in rheumatology studies.
The Max Planck Institute of Psychiatry is a scientific institute based in the city of Munich in Germany specializing in psychiatry. Currently directed by Elisabeth Binder and Alon Chen, it is one of the 81 institutes in the Max Planck Society.
Jules Angst is a Swiss academic who is Emeritus Professor of Psychiatry at Zurich University in Zurich, Switzerland, and Honorary Doctor of Heidelberg University in Heidelberg, Germany.
The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology. The ECNP “is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health”. The ECNP organises a number of activities to achieve this aim, such as a yearly congress, workshops, seminars, New Frontiers Meetings, publications, awards, supported talks and much more.
Sodium-dependent neutral amino acid transporter B(0)AT2 is a protein that in humans is encoded by the SLC6A15 gene.
Barbara Jacquelyn Sahakian, is professor of clinical neuropsychology at the department of psychiatry and Medical Research Council (MRC)/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge. She is also an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge. She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.
Gitte Moos Knudsen is a Danish translational neurobiologist and clinical neurologist, and Clinical Professor and Chief Physician at the Department of Clinical Medicine, Neurology, Psychiatry and Sensory Sciences, at Copenhagen University Hospital. She graduated from Lyngby Statsskole, just north of Copenhagen, before gaining entrance to medicine, where she received her MD from University of Copenhagen in 1984, and became a Board certified user of radioisotopes in 1986. She sat the FMGEMS exam (US) in 1989. She became Board certified in neurology in 1994 and received her DMSc (Dr.Med.) from University of Copenhagen in 1994. She currently resides in Copenhagen, and is married to Tore Vulpius. She has 3 children.
The genetic influences of post-traumatic stress disorder (PTSD) are not understood well due to the limitations of any genetic study of mental illness; in that, it cannot be ethically induced in selected groups. Because of this, all studies must use naturally occurring groups with genetic similarities and differences, thus the amount of data is limited. Still, genetics play some role in the development of PTSD.
Mark J. Millan is a neuroscientist specialising in the study and improved treatment of disorders of brain. He was the Director of Pharmacological Innovation for the Central Nervous System (CNS) at the Institut de Recherché de Servier (IDRS) in Paris, France. He is also the Secretary of the European College of Neuropsychopharmacology. Currently he is a Visiting Professor in the School of Psychology and Neuroscience at the University of Glasgow. Born in Edinburgh, he is the son of former Scottish Labour Party Leader and European Commissioner, Bruce Millan. He studied at Cambridge University and then spent ten years at the Max Planck Institute of Psychiatry, Munich, before moving to Paris.
Martien J.H. Kas is associate professor in the Department of Translational Neuroscience, Brain Center Rudolf Magnus, at the University Medical Center Utrecht, where he leads a work group entitled "Translational Behavioral Genetics" that researches cross-species behavioral genetics to better understand origins and develop treatments for psychiatric disorders.
Astrid Linthorst is a professor of neuroscience at the School of Clinical Sciences at the University of Bristol, UK. Specializing in the neurochemistry and neuroendocrinology of stress and behavior, she heads a research group on the mechanisms that support coping with stress in the brain. She is also chair of the Scientific Programme Committee of the ECNP Congress and a member of the European College of Neuropsychopharmacology (ECNP) Executive Committee.
Supplementing the medical model of depression, many researchers have begun to conceptualize ways in which the historical legacies of racism and colonialism create depressive conditions. Given the lived experiences of marginalized peoples, ranging from conditions of migration, class stratification, cultural genocide, labor exploitation, and social immobility, depression can be seen as a "rational response to global conditions", according to Ann Cvetkovich.
Hans-Ulrich Wittchen is a clinical psychologist, psychotherapist and epidemiologist. He has been a head of the Institute of Clinical Psychology and Psychotherapy and the Center of Clinical Epidemiology and Longitudinal Studies (CELOS) at the Technische Universität Dresden. Since 2018, he is leading the research group "Clinical Psychology and Psychotherapy Research" at the Psychiatric Clinic of Ludwig-Maximilians-Universität München and directs the IAP-TU Dresden GmbH in Dresden.
Epigenetics of anxiety and stress–related disorders is the field studying the relationship between epigenetic modifications of genes and anxiety and stress-related disorders, including mental health disorders such as generalized anxiety disorder (GAD), post-traumatic stress disorder, obsessive-compulsive disorder (OCD), and more. These changes can lead to transgenerational stress inheritance.
Dr. Natalie Matosin is an Australian scientist known for research into the impacts of the human brain in health and disease, and particularly stress and its role in mental illness. Matosin's research has been published in prestigious academic journals, as well as on The Conversation. Matosin spoke at TEDx Hamburg in June 2017 and is the 2021 Al & Val Rosenstrauss Fellow. She was previously a National Health and Medical Research Council CJ Martin Early Career Research Fellow, and Alexander von Humboldt Fellow. In 2017, Matosin was listed as a Forbes 30 Under 30 in Europe in the category of Science & Healthcare, placing her in the top 1% of innovators worldwide.
Marie Åsberg is a Swedish psychiatrist. She was based at the Karolinska Institute until retirement in 2004.
Carolyn I. Rodriguez is a Puerto Rican psychiatrist, neuroscientist, and clinical researcher developing treatments for obsessive compulsive disorder as well as mapping circuit dysfunction in the human brain. Rodriguez holds appointments in both clinical and academic departments at Stanford University. Rodriguez is a Clinical Lab Director at the Stanford Center for Cognitive and Neurobiological Imaging, an associate professor and Associate Chair of Psychiatry and Behavioral Sciences, and a Director of several specialized translational research programs.
References
- ↑ "The Executive Committee". ecnp.eu. Archived from the original on 6 July 2015. Retrieved 4 November 2015.
- 1 2 "Elisabeth Binder, MD, PhD". med.emory.edu/index.html. Archived from the original on 27 September 2018. Retrieved 4 November 2015.
- ↑ "Binder, Elisabeth". mpg.de/en. Retrieved 4 November 2015.
- ↑ "Dr. Elisabeth Binder". AcademiaNet. Retrieved 5 November 2015.
- ↑ "Elisabeth Binder". German Academy of Sciences Leopoldina. Retrieved 26 May 2021.
- ↑ Search Results for author Binder EB on PubMed .
